Tolcapone and fulminant hepatitis

被引：139

作者：

Assal, F ^{[1
]}

Spahr, L

Hadengue, A

Rubbici-Brandt, L

Burkhard, PR

机构：

[1] Univ Hosp, Dept Neurol, CH-1211 Geneva 14, Switzerland

[2] Univ Hosp, Dept Gastroenterol & Hepatol, CH-1211 Geneva, Switzerland

[3] Univ Hosp, Dept Pathol, CH-1211 Geneva 14, Switzerland

来源：

LANCET | 1998年 / 352卷 / 9132期

关键词：

D O I：

10.1016/S0140-6736(05)61511-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：958 / 958

页数：1

相关论文

共 4 条

[1] Catechol-O-methyltransferase inhibition with tolcapone reduces the ''wearing off'' phenomenon and levodopa requirements in fluctuating parkinsonian patients
Baas, H
Beiske, AG
Ghika, J
Jackson, M
Oertel, WH
Poewe, W
Ransmayr, G
Auff, E
Volc, D
Dupont, E
Mikkelsen, B
Wermuth, L
WommPetersen, J
Benecke, R
Eichhom, T
Kolbe, H
Oertel, W
Schimrigk, K
Olsson, JE
Palhagen, S
Burgunder, JM
Ghika, A
Regli, F
Steck, A
Medcalf, P
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (04) : 421 - 428
[2] OERTEL WH, 1998, CLIN NEUROPHARMACOL, V21, P17
[3] Tolcapone improves motor function in parkinsonian patients with the ''wearing-off'' phenomenon: A double-blind, placebo-controlled, multicenter trial
Rajput, AH
Martin, W
SaintHilaire, MH
Dorflinger, E
Pedder, S
[J]. NEUROLOGY, 1997, 49 (04) : 1066 - 1071
[4] Tolcapone in stable Parkinson's disease: Efficacy and safety of long-term treatment
Waters, CH
Kurth, M
Bailey, P
Shulman, LM
LeWitt, P
Dorflinger, E
Deptula, D
Pedder, S
[J]. NEUROLOGY, 1997, 49 (03) : 665 - 671